Aerocrine Release: National Institute for Clinical Excellence (NICE) Recommends The Use Of Exhaled Nitric Oxide (Feno) Testing To Help Diagnose And Manage Asthma

Published: Apr 02, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Solna (Sweden) – Aerocrine AB (OMX Nordic Exchange: AERO) today announced that NICE (National Institute for Health and Care Excellence) has published guidelines ( g eAsthma.jsp) recommending the use of Aerocrine’s NIOX MINO® and NIOX VERO® to help guide the diagnosis and management of asthma in both adults and children.

Help employers find you! Check out all the jobs and post your resume.

Back to news